LitCovid-sample-Enju  

PMC:7205724 / 2521-2812 JSONTXT 14 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T394 0-1 DT denotes A
T395 2-12 VBN denotes randomized
T396 13-23 VBN denotes controlled
T397 24-29 NN denotes trial
T398 30-32 IN denotes of
T399 33-36 CD denotes 199
T400 37-49 VBN denotes hospitalized
T401 50-56 NNS denotes adults
T402 57-61 IN denotes with
T403 62-71 VBN denotes confirmed
T404 72-80 NN denotes COVID-19
T405 81-93 VBD denotes demonstrated
T406 94-96 DT denotes no
T407 97-103 JJ denotes actual
T408 104-114 NN denotes difference
T409 115-122 IN denotes between
T410 123-131 NNS denotes patients
T411 132-135 WP denotes who
T412 136-144 VBD denotes received
T413 145-164 NN denotes lopinavir-ritonavir
T414 165-168 CC denotes and
T415 169-177 NNS denotes patients
T416 178-181 WP denotes who
T417 182-190 VBD denotes received
T418 191-199 JJ denotes standard
T419 200-204 NN denotes care
T420 205-210 RB denotes alone
T421 211-213 IN denotes in
T422 214-222 JJ denotes clinical
T423 223-234 NN denotes improvement
T424 234-235 -COMMA- denotes ,
T425 236-241 NN denotes death
T426 242-246 NN denotes rate
T427 246-247 -COMMA- denotes ,
T428 248-251 CC denotes and
T429 252-260 JJ denotes positive
T430 261-266 NN denotes virus
T431 267-271 NN denotes test
T432 272-276 NN denotes rate
T433 277-279 IN denotes at
T434 280-283 NN denotes day
T435 284-286 CD denotes 28
T436 287-288 -LRB- denotes [
T437 288-289 CD denotes 1
T438 289-290 -RRB- denotes ]
R393 T397 T394 arg1Of trial,A
R394 T397 T395 arg2Of trial,randomized
R395 T397 T396 arg2Of trial,controlled
R396 T397 T398 arg1Of trial,of
R397 T401 T398 arg2Of adults,of
R398 T401 T399 arg1Of adults,199
R399 T401 T400 arg2Of adults,hospitalized
R400 T401 T402 arg1Of adults,with
R401 T404 T402 arg2Of COVID-19,with
R402 T404 T403 arg2Of COVID-19,confirmed
R403 T397 T405 arg1Of trial,demonstrated
R404 T408 T405 arg2Of difference,demonstrated
R405 T408 T406 arg1Of difference,no
R406 T408 T407 arg1Of difference,actual
R407 T408 T409 arg1Of difference,between
R408 T410 T409 arg2Of patients,between
R409 T410 T411 arg1Of patients,who
R410 T410 T412 arg1Of patients,received
R411 T414 T412 arg2Of and,received
R412 T413 T414 arg1Of lopinavir-ritonavir,and
R413 T415 T414 arg2Of patients,and
R414 T410 T416 arg1Of patients,who
R415 T410 T417 arg1Of patients,received
R416 T419 T417 arg2Of care,received
R417 T419 T418 arg1Of care,standard
R418 T419 T420 arg1Of care,alone
R419 T417 T421 arg1Of received,in
R420 T428 T421 arg2Of and,in
R421 T423 T422 arg1Of improvement,clinical
R422 T423 T424 arg1Of improvement,","
R423 T426 T424 arg2Of rate,","
R424 T426 T425 arg1Of rate,death
R425 T428 T427 arg1Of and,","
R426 T424 T428 arg1Of ",",and
R427 T432 T428 arg2Of rate,and
R428 T432 T429 arg1Of rate,positive
R429 T432 T430 arg1Of rate,virus
R430 T432 T431 arg1Of rate,test
R431 T432 T433 arg1Of rate,at
R432 T434 T433 arg2Of day,at
R433 T434 T435 arg1Of day,28
R434 T417 T436 arg1Of received,[
R435 T437 T436 arg2Of 1,[
R436 T438 T436 arg3Of ],[